vs
Side-by-side financial comparison of P3 Health Partners Inc. (PIII) and Westrock Coffee Co (WEST). Click either name above to swap in a different company.
P3 Health Partners Inc. is the larger business by last-quarter revenue ($384.8M vs $339.5M, roughly 1.1× Westrock Coffee Co). Westrock Coffee Co runs the higher net margin — -6.6% vs -19.6%, a 13.0% gap on every dollar of revenue. On growth, Westrock Coffee Co posted the faster year-over-year revenue change (48.3% vs 3.8%). Over the past eight quarters, Westrock Coffee Co's revenue compounded faster (32.8% CAGR vs -0.5%).
P3 Health Partners Inc. is a population health management and value-based care services firm operating primarily in the United States. It partners with primary care providers and health systems to deliver coordinated, high-quality care for patient populations, especially Medicare Advantage beneficiaries, focusing on improving health outcomes and lowering unnecessary healthcare costs.
Westrock Coffee Co is a global integrated coffee, tea and functional beverage solutions provider. It sources, roasts, manufactures and distributes coffee products, ready-to-drink beverages and custom formulations for retail, foodservice and commercial clients across North America and other key markets.
PIII vs WEST — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $384.8M | $339.5M |
| Net Profit | $-75.5M | $-22.6M |
| Gross Margin | — | 11.5% |
| Operating Margin | -40.0% | -2.6% |
| Net Margin | -19.6% | -6.6% |
| Revenue YoY | 3.8% | 48.3% |
| Net Profit YoY | -28.8% | 8.3% |
| EPS (diluted) | $-23.08 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $384.8M | $339.5M | ||
| Q3 25 | $345.3M | $354.8M | ||
| Q2 25 | $355.8M | $280.9M | ||
| Q1 25 | $373.2M | $213.8M | ||
| Q4 24 | $370.7M | $229.0M | ||
| Q3 24 | $362.1M | $220.9M | ||
| Q2 24 | $379.2M | $208.4M | ||
| Q1 24 | $388.5M | $192.5M |
| Q4 25 | $-75.5M | $-22.6M | ||
| Q3 25 | $-31.6M | $-19.1M | ||
| Q2 25 | $-20.4M | $-21.6M | ||
| Q1 25 | $-20.5M | $-27.2M | ||
| Q4 24 | $-58.6M | $-24.6M | ||
| Q3 24 | $-46.5M | $-14.3M | ||
| Q2 24 | $-12.0M | $-17.8M | ||
| Q1 24 | $-18.7M | $-23.7M |
| Q4 25 | — | 11.5% | ||
| Q3 25 | — | 11.7% | ||
| Q2 25 | — | 14.7% | ||
| Q1 25 | — | 13.6% | ||
| Q4 24 | — | 16.6% | ||
| Q3 24 | — | 16.8% | ||
| Q2 24 | — | 19.9% | ||
| Q1 24 | — | 19.4% |
| Q4 25 | -40.0% | -2.6% | ||
| Q3 25 | -12.8% | -2.4% | ||
| Q2 25 | -9.6% | -5.3% | ||
| Q1 25 | -10.2% | -6.1% | ||
| Q4 24 | -37.4% | -4.3% | ||
| Q3 24 | -29.5% | -5.8% | ||
| Q2 24 | -8.3% | -7.9% | ||
| Q1 24 | -11.3% | -5.3% |
| Q4 25 | -19.6% | -6.6% | ||
| Q3 25 | -9.1% | -5.4% | ||
| Q2 25 | -5.7% | -7.7% | ||
| Q1 25 | -5.5% | -12.7% | ||
| Q4 24 | -15.8% | -10.7% | ||
| Q3 24 | -12.8% | -6.5% | ||
| Q2 24 | -3.2% | -8.5% | ||
| Q1 24 | -4.8% | -12.3% |
| Q4 25 | $-23.08 | $-0.22 | ||
| Q3 25 | $-9.67 | $-0.20 | ||
| Q2 25 | $-6.23 | $-0.23 | ||
| Q1 25 | $-6.28 | $-0.29 | ||
| Q4 24 | $-23.13 | $-0.26 | ||
| Q3 24 | $-15.70 | $-0.16 | ||
| Q2 24 | $-7.37 | $-0.20 | ||
| Q1 24 | $-7.86 | $-0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $25.0M | $49.9M |
| Total DebtLower is stronger | $228.4M | $444.1M |
| Stockholders' EquityBook value | $-155.2M | $-1.9M |
| Total Assets | $656.6M | $1.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $25.0M | $49.9M | ||
| Q3 25 | $37.7M | $34.0M | ||
| Q2 25 | $38.6M | $44.0M | ||
| Q1 25 | $40.1M | $33.1M | ||
| Q4 24 | $38.8M | $26.2M | ||
| Q3 24 | $63.0M | $22.4M | ||
| Q2 24 | $73.1M | $24.3M | ||
| Q1 24 | $27.3M | $12.6M |
| Q4 25 | $228.4M | $444.1M | ||
| Q3 25 | $252.8M | — | ||
| Q2 25 | $182.0M | — | ||
| Q1 25 | $171.1M | — | ||
| Q4 24 | $108.9M | $393.1M | ||
| Q3 24 | $133.2M | — | ||
| Q2 24 | $133.1M | — | ||
| Q1 24 | $118.1M | — |
| Q4 25 | $-155.2M | $-1.9M | ||
| Q3 25 | $-18.7M | $11.4M | ||
| Q2 25 | $44.5M | $18.2M | ||
| Q1 25 | $63.3M | $71.4M | ||
| Q4 24 | $75.9M | $97.5M | ||
| Q3 24 | $120.5M | $110.3M | ||
| Q2 24 | $166.8M | $81.5M | ||
| Q1 24 | $146.6M | $91.7M |
| Q4 25 | $656.6M | $1.2B | ||
| Q3 25 | $683.6M | $1.2B | ||
| Q2 25 | $731.6M | $1.2B | ||
| Q1 25 | $783.9M | $1.1B | ||
| Q4 24 | $783.4M | $1.1B | ||
| Q3 24 | $833.3M | $1.1B | ||
| Q2 24 | $892.8M | $1.1B | ||
| Q1 24 | $855.9M | $983.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 4.09× | — | ||
| Q1 25 | 2.71× | — | ||
| Q4 24 | 1.43× | 4.03× | ||
| Q3 24 | 1.11× | — | ||
| Q2 24 | 0.80× | — | ||
| Q1 24 | 0.81× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-25.7M | $36.7M |
| Free Cash FlowOCF − Capex | — | $27.8M |
| FCF MarginFCF / Revenue | — | 8.2% |
| Capex IntensityCapex / Revenue | — | 2.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-107.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-25.7M | $36.7M | ||
| Q3 25 | $-15.4M | $-26.6M | ||
| Q2 25 | $-16.6M | $-7.0M | ||
| Q1 25 | $-33.5M | $-22.1M | ||
| Q4 24 | $-57.2M | $2.8M | ||
| Q3 24 | $-22.6M | $-332.0K | ||
| Q2 24 | $-10.2M | $-23.7M | ||
| Q1 24 | $-20.0M | $8.0M |
| Q4 25 | — | $27.8M | ||
| Q3 25 | — | $-44.7M | ||
| Q2 25 | — | $-27.5M | ||
| Q1 25 | — | $-63.4M | ||
| Q4 24 | — | $-15.4M | ||
| Q3 24 | — | $-36.7M | ||
| Q2 24 | — | $-59.9M | ||
| Q1 24 | — | $-60.9M |
| Q4 25 | — | 8.2% | ||
| Q3 25 | — | -12.6% | ||
| Q2 25 | — | -9.8% | ||
| Q1 25 | — | -29.7% | ||
| Q4 24 | — | -6.7% | ||
| Q3 24 | — | -16.6% | ||
| Q2 24 | — | -28.7% | ||
| Q1 24 | — | -31.7% |
| Q4 25 | — | 2.6% | ||
| Q3 25 | — | 5.1% | ||
| Q2 25 | — | 7.3% | ||
| Q1 25 | — | 19.3% | ||
| Q4 24 | 0.0% | 7.9% | ||
| Q3 24 | 0.0% | 16.5% | ||
| Q2 24 | 0.0% | 17.4% | ||
| Q1 24 | 0.0% | 35.8% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PIII
| Capitated Revenue | $366.2M | 95% |
| Health Care Patient Service | $18.6M | 5% |
| Health Care Care Coordination Management Fees | $2.7M | 1% |
WEST
| Coffee And Tea | $202.6M | 60% |
| Flavors Extracts And Ingredients | $69.6M | 21% |
| Sustainable Sourcing And Traceability Segments | $66.9M | 20% |
